| Project/Area Number |
11671102
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Endocrinology
|
|---|
| Research Institution | Fujita Health University |
|---|
Principal Investigator |
OSHIMA Hisaji Fujita Health University School of Medicine, Internal Medicine, Assistant Professor, 医学部, 助教授 (90138008)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KATAYAMA Masao Fujita Health University School of Medicine, Intrenal Medicine, Associate Professor, 医学部, 講師 (00278285)
澤田 誠 藤田保健衛生大学, 総合医科学研究所, 教授 (10187297)
|
|---|
| Project Period (FY) |
1999 – 2000
|
| Project Status |
Completed (Fiscal Year 2000)
|
| Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2000: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1999: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
|---|
| Keywords | glucocorticoids / receptors / steroids / transcription |
|---|
| Research Abstract |
Glucocorticoid receptor was a ligand-inducible transcription factor, and activates or inhibit transcription of target genes. We, in this project, have identified and clarified glucocorticoid modulatory elements binding proteins (GMEB) which works as a gene specific and tissue specific modulator of regulation of gene transcription by glucocorticoids. GMEBs are now identified as a heteroologomeric complex (GMEB-1 and GMEB-2) present in cytoplasma and nucleus in cells. GMEB-1 and GMEB-2 are 68KDa and 88KDa proteins respectively. Cloning of GMEB-1 and GMEB-2 cDAA shows that these proteins have unique primary protein sequences. We find also that GMEB functions as a transcription factor where they bind to DNA as a sequence specific manner. In vitro, GMEB binds to a palindromic sequence which is most preferentialy GCGA/CNNNG/TCGC.Biological activities of GMEB can vary in different tissues and also by a change in the growth conditions of cells. In addition, a splice variant of GMEB-1 was identified and sequenced. These findings can be a most hopeful evidence to undrestand a gene and tissue specific modulation of the glucocorticoid hormone actions and to develop more specific and powerful glucocorticoid therapies where less adverse effects are expected.
|
